These emerging therapies , Retatrutide, represent a remarkable advancement in treating metabolic dysfunction and possibly other conditions . They all are grouped as GLP-1 receptor agonists , signifying these substances to emulate the natural GLP-1 peptide, enhancing glucose production and reducin